Web Date: October 8, 2013
Copper Complex Lights Up Alzheimer’s Lesions
In the last decade, doctors have started to use small-molecule tracers to detect clumped protein plaques in the brains of living Alzheimer’s disease patients. Last year, the Food and Drug Administration approved a fluorine-18-based compound that binds to the plaques and produces a signal detectable through positron emission tomography (PET). Now Australian researchers present a new copper complex that does the same but has a longer half-life (J. Am. Chem. . . .
You Do Not Have Access to C&EN Protected Content.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society